| Literature DB >> 32497523 |
Yimeng Gao1, Radovan Vasic2, Yuanbin Song2, Rhea Teng2, Chengyang Liu2, Rana Gbyli2, Giulia Biancon2, Raman Nelakanti3, Kirsten Lobben2, Eriko Kudo4, Wei Liu2, Anastasia Ardasheva2, Xiaoying Fu2, Xiaman Wang2, Poorval Joshi2, Veronica Lee2, Burak Dura5, Gabriella Viero6, Akiko Iwasaki7, Rong Fan5, Andrew Xiao3, Richard A Flavell8, Hua-Bing Li9, Toma Tebaldi10, Stephanie Halene11.
Abstract
N6-methyladenosine (m6A) is the most abundant RNA modification, but little is known about its role in mammalian hematopoietic development. Here, we show that conditional deletion of the m6A writer METTL3 in murine fetal liver resulted in hematopoietic failure and perinatal lethality. Loss of METTL3 and m6A activated an aberrant innate immune response, mediated by the formation of endogenous double-stranded RNAs (dsRNAs). The aberrantly formed dsRNAs were long, highly m6A modified in their native state, characterized by low folding energies, and predominantly protein coding. We identified coinciding activation of pattern recognition receptor pathways normally tasked with the detection of foreign dsRNAs. Disruption of the aberrant immune response via abrogation of downstream Mavs or Rnasel signaling partially rescued the observed hematopoietic defects in METTL3-deficient cells in vitro and in vivo. Our results suggest that m6A modification protects against endogenous dsRNA formation and a deleterious innate immune response during mammalian hematopoietic development.Entities:
Keywords: METTL3; N(6)-methyladenosine; RNA modification; double-stranded RNA; dsRNA; epitranscriptome; hematopoiesis; hematopoietic development; innate immune response; m6A
Mesh:
Substances:
Year: 2020 PMID: 32497523 PMCID: PMC7408742 DOI: 10.1016/j.immuni.2020.05.003
Source DB: PubMed Journal: Immunity ISSN: 1074-7613 Impact factor: 31.745